European Journal of Gastroenterology & Hepatology

Papers
(The H4-Index of European Journal of Gastroenterology & Hepatology is 16. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Paper Alert52
String used for oesophageal capsule endoscopy: help or hindrance?32
A comparative study on nosocomial and community-acquired spontaneous bacterial peritonitis in patients with liver cirrhosis at a university hospital30
Effectiveness and safety of newly introduced endoscopic submucosal dissection in a Western center: a real-life study29
Quality of care in inflammatory bowel disease from patient’s perspective using QUOTE-IBD: a Greek multicenter prospective study28
Paper alert25
Hepatocellular carcinoma arising from ectopic liver tissue: a systematic review of the literature23
Suppressed serological vitamin A in patients with liver cirrhosis is associated with impaired liver function and clinical detoriation23
Mid- to long-term outcomes of initial transjugular intrahepatic portosystemic shunt versus anticoagulation for pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome20
Upregulated NORAD is implicated in apoptosis, inflammation, and oxidative stress in ulcerative colitis through the nuclear factor-κappaB signaling20
Fib-4 index predicts prognosis after achievement of sustained virologic response following direct-acting antiviral treatment in patients with hepatitis C virus infection19
Association of left ventricular diastolic dysfunction with inflammatory activity, renal dysfunction, and liver-related mortality in patients with cirrhosis and ascites19
Coexistence of metabolic-associated fatty liver disease and autoimmune or toxic liver disease18
Cardiac involvement in Wilson’s disease: a retrospective cohort study17
Can albumin reduce the mortality of patients with cirrhosis and ascites? A meta-analysis of randomized controlled trials17
Endoscopic retrograde cholangiopancreatography discharge tool combined with rapid trypsinogen-2 test to predict same-day discharge: a prospective cohort study16
0.07495903968811